Susquehanna Fundamental Investments, LLC Bio Xcel Therapeutics, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
Shares
2 transactions
Others Institutions Holding BTAI
# of Institutions
78Shares Held
7.26MCall Options Held
101KPut Options Held
205K-
Armistice Capital, LLC New York, NY2.99MShares$1.76 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA970KShares$572,5530.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$260,0040.0% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$157,3640.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA204KShares$120,1320.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $16.5M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...